NPI: 1730123175 · GREENVILLE, SC 29601 · General Acute Care Hospital · NPI assigned 06/16/2006
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (VP REIMBURSEMENT) |
| NPI Enumeration Date | 06/16/2006 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 97,110 | $1.87M |
| 2019 | 91,052 | $1.53M |
| 2020 | 73,086 | $1.41M |
| 2021 | 110,580 | $2.26M |
| 2022 | 139,200 | $3.85M |
| 2023 | 124,782 | $3.86M |
| 2024 | 132,400 | $3.02M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 41,807 | 33,873 | $2.88M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 35,230 | 30,412 | $1.89M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 14,681 | 12,377 | $1.34M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6,510 | 5,577 | $771K |
| 80048 | Basic metabolic panel (calcium, ionized) | 12,241 | 8,804 | $727K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,315 | 3,177 | $698K |
| 82962 | 16,848 | 7,029 | $654K | |
| 36415 | Collection of venous blood by venipuncture | 16,288 | 10,987 | $555K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8,905 | 6,205 | $467K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7,961 | 7,063 | $365K |
| 81025 | 11,424 | 10,135 | $327K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2,694 | 2,545 | $319K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 30,692 | 26,423 | $295K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,932 | 3,352 | $283K |
| 96375 | Therapeutic injection; each additional sequential IV push | 10,412 | 8,332 | $279K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8,773 | 2,428 | $265K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 353 | 309 | $232K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,841 | 3,213 | $225K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,988 | 4,470 | $222K |
| 71046 | Radiologic examination, chest; 2 views | 13,529 | 11,900 | $208K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3,229 | 2,453 | $207K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,520 | 1,360 | $199K |
| 81001 | 12,748 | 11,314 | $197K | |
| 87210 | 2,213 | 2,018 | $189K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1,289 | 1,143 | $184K |
| 81003 | 13,115 | 11,475 | $168K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4,042 | 3,702 | $161K |
| 70450 | Computed tomography, head or brain; without contrast material | 6,308 | 5,571 | $144K |
| 73562 | 2,613 | 2,183 | $129K | |
| 73610 | 1,241 | 1,108 | $129K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,717 | 2,558 | $122K |
| 93971 | 1,308 | 1,174 | $120K | |
| 82565 | 1,566 | 1,336 | $120K | |
| 84132 | 2,361 | 1,952 | $118K | |
| 86900 | 1,866 | 1,582 | $113K | |
| 73630 | 1,650 | 1,428 | $111K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 5,634 | 4,420 | $103K |
| 72100 | 2,835 | 2,596 | $103K | |
| 73030 | 1,800 | 1,617 | $97K | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18,164 | 15,432 | $95K |
| 84702 | 1,606 | 1,351 | $92K | |
| 73130 | 829 | 735 | $88K | |
| 87081 | 847 | 769 | $84K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,373 | 2,167 | $80K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,966 | 4,435 | $68K |
| 71250 | 496 | 481 | $67K | |
| 73110 | 529 | 463 | $62K | |
| 71045 | Radiologic examination, chest; single view | 9,999 | 8,381 | $62K |
| 87040 | 3,554 | 2,211 | $58K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 46,338 | 36,207 | $53K |
| 93458 | 359 | 308 | $52K | |
| 72040 | 1,225 | 1,108 | $51K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 512 | 472 | $48K |
| 96376 | 3,892 | 2,237 | $44K | |
| J1644 | Injection, heparin sodium, per 1000 units | 6,587 | 2,590 | $43K |
| G0378 | Hospital observation service, per hour | 9,187 | 3,023 | $40K |
| 87186 | 1,734 | 1,487 | $37K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 133 | 111 | $35K |
| 73502 | 1,462 | 1,299 | $34K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 468 | 410 | $31K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 831 | 751 | $30K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 896 | 521 | $29K |
| 85018 | 1,206 | 857 | $29K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3,332 | 1,410 | $28K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 253 | 225 | $27K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,763 | 916 | $24K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 5,914 | 3,603 | $23K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 19,705 | 16,203 | $23K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,556 | 2,295 | $23K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 218 | 180 | $23K |
| 80050 | General health panel | 705 | 618 | $22K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 500 | 422 | $22K |
| 74018 | 572 | 513 | $22K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 733 | 666 | $21K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 10,788 | 8,836 | $19K |
| 84484 | 19,039 | 10,820 | $19K | |
| 87807 | 99 | 91 | $18K | |
| C1769 | Guide wire | 2,456 | 2,087 | $18K |
| 87070 | 416 | 347 | $17K | |
| 97161 | 1,245 | 1,095 | $16K | |
| 85027 | 7,240 | 5,716 | $16K | |
| 85610 | 3,845 | 3,003 | $15K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 968 | 879 | $14K |
| 76830 | Ultrasound, transvaginal | 244 | 234 | $12K |
| 74022 | 1,144 | 998 | $12K | |
| 81015 | 1,149 | 1,019 | $12K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 799 | 353 | $11K |
| 83735 | 12,369 | 9,528 | $11K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,630 | 1,038 | $11K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 14,932 | 12,156 | $10K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 36 | 35 | $10K |
| J2704 | Injection, propofol, 10 mg | 10,890 | 7,655 | $10K |
| 12001 | 67 | 54 | $9K | |
| 95811 | 42 | 39 | $9K | |
| 87634 | 293 | 281 | $9K | |
| 94760 | 2,312 | 1,249 | $9K | |
| 82077 | 1,793 | 1,484 | $8K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 180 | 163 | $8K |
| 97162 | 584 | 543 | $8K | |
| 70486 | 59 | 57 | $7K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 327 | 302 | $7K |
| J3490 | Unclassified drugs | 3,958 | 2,838 | $7K |
| 95806 | 58 | 56 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,202 | 9,776 | $6K |
| J7050 | Infusion, normal saline solution, 250 cc | 4,439 | 3,417 | $6K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,088 | 981 | $6K |
| 93970 | 28 | 25 | $6K | |
| 80061 | Lipid panel | 3,532 | 3,131 | $6K |
| 73080 | 46 | 38 | $5K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,291 | 458 | $5K |
| 88304 | 92 | 74 | $5K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 2,087 | 1,764 | $5K |
| 83690 | 14,280 | 12,017 | $4K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 13 | 13 | $4K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,195 | 1,109 | $4K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 57 | 52 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | 13,580 | 10,826 | $4K |
| 83605 | 5,906 | 4,624 | $4K | |
| 85379 | 2,506 | 2,279 | $4K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,837 | 3,507 | $4K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 5,917 | 4,534 | $4K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 4,504 | 3,488 | $4K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 13 | 13 | $4K |
| 73590 | 112 | 100 | $4K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 418 | 393 | $4K |
| J0780 | Injection, prochlorperazine, up to 10 mg | 517 | 463 | $4K |
| 83880 | 4,321 | 3,641 | $3K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 378 | 349 | $3K |
| 70496 | 111 | 96 | $3K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 832 | 783 | $3K |
| J1815 | Injection, insulin, per 5 units | 460 | 225 | $3K |
| J1940 | Injection, furosemide, up to 20 mg | 1,120 | 739 | $3K |
| 86850 | 1,222 | 1,007 | $3K | |
| 10060 | 30 | 26 | $3K | |
| 80047 | 63 | 61 | $3K | |
| 85652 | 668 | 601 | $2K | |
| 80179 | 318 | 270 | $2K | |
| 99152 | 2,429 | 2,056 | $2K | |
| 86140 | 1,732 | 1,511 | $2K | |
| 74019 | 55 | 54 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 5,752 | 4,469 | $2K |
| C9113 | Injection, pantoprazole sodium, per vial | 295 | 207 | $2K |
| 80143 | 310 | 254 | $2K | |
| 86592 | 340 | 302 | $2K | |
| J2060 | Injection, lorazepam, 2 mg | 1,574 | 1,266 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | 3,136 | 2,768 | $2K |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 390 | 282 | $2K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,347 | 1,188 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 371 | 358 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 7,268 | 6,261 | $2K |
| 77001 | 12 | 12 | $2K | |
| A4565 | Slings | 59 | 58 | $1K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 2,223 | 1,890 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 351 | 332 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,322 | 2,929 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 9,653 | 8,420 | $1K |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 899 | 648 | $1K |
| 86780 | 174 | 162 | $1K | |
| 74230 | 13 | 13 | $1K | |
| 87340 | 340 | 300 | $977.54 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 830 | 760 | $942.01 |
| 94761 | 452 | 358 | $901.29 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1,554 | 1,130 | $891.83 |
| 82728 | 358 | 314 | $886.49 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 505 | 440 | $821.77 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 274 | 227 | $788.05 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,905 | 2,353 | $775.19 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,181 | 6,335 | $765.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,104 | 5,282 | $758.88 |
| 97535 | Self-care/home management training, each 15 minutes | 508 | 300 | $753.35 |
| 84145 | 2,356 | 2,082 | $735.55 | |
| 72070 | 29 | 27 | $678.87 | |
| 82570 | 467 | 403 | $673.32 | |
| 84100 | 81 | 57 | $653.54 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 118 | 111 | $610.18 |
| 97165 | 412 | 353 | $594.24 | |
| 84550 | 213 | 197 | $583.35 | |
| 86803 | 876 | 802 | $533.87 | |
| 73090 | 12 | 12 | $462.68 | |
| 82803 | 330 | 277 | $446.92 | |
| 76770 | 13 | 12 | $443.19 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,813 | 1,551 | $411.76 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 407 | 340 | $405.68 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 552 | 495 | $403.14 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,648 | 1,316 | $383.27 |
| 87088 | 1,179 | 1,048 | $337.54 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,094 | 966 | $323.48 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3,980 | 3,635 | $306.83 |
| 84703 | 33 | 29 | $217.48 | |
| 84439 | 874 | 772 | $164.41 | |
| 96367 | 14 | 13 | $91.85 | |
| 94762 | 1,182 | 1,026 | $81.15 | |
| 76801 | 58 | 55 | $78.42 | |
| 82043 | 247 | 205 | $77.98 | |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 12 | 12 | $76.50 |
| 82607 | 398 | 339 | $71.36 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 685 | 603 | $68.35 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 696 | 607 | $50.00 |
| 90714 | 225 | 205 | $37.93 | |
| 76937 | 541 | 494 | $35.96 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 1,717 | 1,473 | $35.18 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 29 | 24 | $27.91 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 132 | 121 | $23.29 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,030 | 920 | $9.54 |
| 86901 | 1,867 | 1,583 | $7.87 | |
| 82550 | 595 | 498 | $5.86 | |
| A9270 | Non-covered item or service | 331 | 163 | $1.32 |
| 80081 | 40 | 40 | $0.00 | |
| 87205 | 570 | 473 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 344 | 308 | $0.00 |
| 85730 | 279 | 232 | $0.00 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 13 | 13 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 125 | 101 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 950 | 827 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 65 | 58 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 308 | 260 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,794 | 1,550 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 29 | 27 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 380 | 241 | $0.00 |
| 70498 | 121 | 108 | $0.00 | |
| 86141 | 104 | 104 | $0.00 | |
| 90686 | 27 | 25 | $0.00 | |
| 84153 | 51 | 44 | $0.00 | |
| 86762 | 49 | 46 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 25 | 25 | $0.00 |
| 80055 | 107 | 103 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 63 | 43 | $0.00 |
| 83550 | 34 | 28 | $0.00 | |
| 86580 | 30 | 25 | $0.00 | |
| J2305 | Injection, nitroglycerin, 5 mg | 36 | 31 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 53 | 42 | $0.00 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 49 | 45 | $0.00 |
| J2372 | Injection, phenylephrine hydrochloride (biorphen), 20 micrograms | 12 | 12 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 36 | 24 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 17 | 12 | $0.00 |
| 83615 | 16 | 15 | $0.00 | |
| 36430 | 17 | 12 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 18 | 17 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 12 | 12 | $0.00 |
| 82746 | 15 | 12 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 329 | 247 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 314 | 306 | $0.00 |
| 94664 | 245 | 185 | $0.00 | |
| 76942 | 395 | 357 | $0.00 | |
| 83540 | 402 | 351 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 125 | 115 | $0.00 |
| 88312 | 547 | 459 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 114 | 95 | $0.00 |
| 80076 | 273 | 249 | $0.00 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 235 | 171 | $0.00 |
| 36600 | 102 | 89 | $0.00 | |
| 90715 | 187 | 169 | $0.00 | |
| 86038 | 14 | 12 | $0.00 | |
| 83020 | 80 | 75 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 203 | 167 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 365 | 352 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 141 | 84 | $0.00 |
| 80074 | 12 | 12 | $0.00 | |
| 43235 | 26 | 26 | $0.00 | |
| 82140 | 13 | 12 | $0.00 | |
| 92611 | 12 | 12 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 62 | 38 | $0.00 |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 49 | 38 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 18 | 13 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 12 | 12 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 33 | 24 | $0.00 |
| 84156 | 14 | 13 | $0.00 | |
| 92610 | 29 | 24 | $0.00 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 27 | 24 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 13 | 13 | $0.00 |